1 study found for:    20124187 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Metastatic Breast Cancer
Conditions: Breast Neoplasms;   HER2 Protein, Human;   Geriatric Health Services
Interventions: Drug: Lapatinib;   Drug: Trastuzumab;   Other: laboratory biomarker analysis;   Other: pharmacological study

Indicates status has not been verified in more than two years